Personalized cancer vaccines are a novel approach to cancer immunotherapy. They are tailored to the unique genetic makeup of an individual's tumor. Moderna is pioneering this field with its mRNA-4157 vaccine, which is designed to elicit a strong immune response against specific mutations present in the patient's cancer cells.
